Genetics and Proteomics

The cause of bipolar disorder remains unclear but several studies have strongly suggested that genetics plays an important role in developing mood disorder.  In general population the individuals with no close family history having a risk to develop these disorders is about 2-3% but the children with a parent or sibling witnessing this disorder are prone to develop approximately 4-6 times. Increasing accuracy for bipolar disorder diagnosis can improve mental health treatment of patients. Recently proteomics become the most applied advanced analytical tool allowing the discovery of protein biomarkers for disease and treatment

 

To present a paper on this track, submit abstract here. Email confirmation will be send upon successful acceptance of the abstract

 

    Related Conference of Genetics and Proteomics

    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Genetics and Proteomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in